Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban

Abstract Background Direct oral anticoagulants (DOAC) including edoxaban are increasingly used for stroke prevention in atrial fibrillation. Despite treatment, annual stroke rate in these patients remains 1–2%. Rapid assessment of coagulation would be useful to guide thrombolysis or reversal therapy...

全面介绍

书目详细资料

Principais autores:	Florian Härtig, Ingvild Birschmann, Andreas Peter, Sebastian Hörber, Matthias Ebner, Matthias Sonnleitner, Charlotte Spencer, Paula Bombach, Maria-Ioanna Stefanou, Johannes Tünnerhoff, Annerose Mengel, Joachim Kuhn, Ulf Ziemann, Sven Poli
格式:	Artigo
语言:	Inglês
出版:	BMC 2021-03-01
丛编:	Neurological Research and Practice
主题:	Point-of-care testing POCT Direct oral anticoagulants DOAC Non-vitamin K antagonist oral anticoagulants NOAC
在线阅读:	https://doi.org/10.1186/s42466-021-00105-4
标签:	添加标签 没有标签, 成为第一个标记此记录!